| UniProt ID | UBP1_HUMAN | |
|---|---|---|
| UniProt AC | O94782 | |
| Protein Name | Ubiquitin carboxyl-terminal hydrolase 1 | |
| Gene Name | USP1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 785 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | Negative regulator of DNA damage repair which specifically deubiquitinates monoubiquitinated FANCD2. [PubMed: 15694335 Also involved in PCNA-mediated translesion synthesis (TLS) by deubiquitinating monoubiquitinated PCNA] | |
| Protein Sequence | MPGVIPSESNGLSRGSPSKKNRLSLKFFQKKETKRALDFTDSQENEEKASEYRASEIDQVVPAAQSSPINCEKRENLLPFVGLNNLGNTCYLNSILQVLYFCPGFKSGVKHLFNIISRKKEALKDEANQKDKGNCKEDSLASYELICSLQSLIISVEQLQASFLLNPEKYTDELATQPRRLLNTLRELNPMYEGYLQHDAQEVLQCILGNIQETCQLLKKEEVKNVAELPTKVEEIPHPKEEMNGINSIEMDSMRHSEDFKEKLPKGNGKRKSDTEFGNMKKKVKLSKEHQSLEENQRQTRSKRKATSDTLESPPKIIPKYISENESPRPSQKKSRVKINWLKSATKQPSILSKFCSLGKITTNQGVKGQSKENECDPEEDLGKCESDNTTNGCGLESPGNTVTPVNVNEVKPINKGEEQIGFELVEKLFQGQLVLRTRCLECESLTERREDFQDISVPVQEDELSKVEESSEISPEPKTEMKTLRWAISQFASVERIVGEDKYFCENCHHYTEAERSLLFDKMPEVITIHLKCFAASGLEFDCYGGGLSKINTPLLTPLKLSLEEWSTKPTNDSYGLFAVVMHSGITISSGHYTASVKVTDLNSLELDKGNFVVDQMCEIGKPEPLNEEEARGVVENYNDEEVSIRVGGNTQPSKVLNKKNVEAIGLLGGQKSKADYELYNKASNPDKVASTAFAENRNSETSDTTGTHESDRNKESSDQTGINISGFENKISYVVQSLKEYEGKWLLFDDSEVKVTEEKDFLNSLSPSTSPTSTPYLLFYKKL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 7 | Phosphorylation | -MPGVIPSESNGLSR -CCCCCCCCCCCCCC | 42.40 | 23927012 | |
| 9 | Phosphorylation | PGVIPSESNGLSRGS CCCCCCCCCCCCCCC | 40.30 | 23401153 | |
| 13 | Phosphorylation | PSESNGLSRGSPSKK CCCCCCCCCCCCCCC | 35.67 | 23401153 | |
| 16 | Phosphorylation | SNGLSRGSPSKKNRL CCCCCCCCCCCCCCC | 25.53 | 25159151 | |
| 18 | Phosphorylation | GLSRGSPSKKNRLSL CCCCCCCCCCCCCCH | 58.94 | 30108239 | |
| 33 | Phosphorylation | KFFQKKETKRALDFT HHHCHHHHHHHCCCC | 34.41 | - | |
| 40 | Phosphorylation | TKRALDFTDSQENEE HHHHCCCCCCHHHHH | 34.11 | 27732954 | |
| 42 | Phosphorylation | RALDFTDSQENEEKA HHCCCCCCHHHHHHH | 36.01 | 17525332 | |
| 48 | Ubiquitination | DSQENEEKASEYRAS CCHHHHHHHHHHHHH | 51.54 | 24816145 | |
| 50 | Phosphorylation | QENEEKASEYRASEI HHHHHHHHHHHHHHH | 46.35 | 23312004 | |
| 52 | Phosphorylation | NEEKASEYRASEIDQ HHHHHHHHHHHHHHH | 14.69 | 23312004 | |
| 55 | Phosphorylation | KASEYRASEIDQVVP HHHHHHHHHHHHHCC | 26.53 | 22167270 | |
| 66 | Phosphorylation | QVVPAAQSSPINCEK HHCCHHHCCCCCCCH | 33.10 | 23401153 | |
| 67 | Phosphorylation | VVPAAQSSPINCEKR HCCHHHCCCCCCCHH | 20.09 | 29255136 | |
| 73 | Ubiquitination | SSPINCEKRENLLPF CCCCCCCHHCCCCCC | 68.18 | 21963094 | |
| 110 | Ubiquitination | PGFKSGVKHLFNIIS CCHHHHHHHHHHHHH | 37.81 | 29967540 | |
| 124 | Sumoylation | SRKKEALKDEANQKD HHHHHHHHHHHHHHC | 61.65 | - | |
| 124 | Sumoylation | SRKKEALKDEANQKD HHHHHHHHHHHHHHC | 61.65 | - | |
| 130 | Acetylation | LKDEANQKDKGNCKE HHHHHHHHCCCCCCH | 62.30 | 19828857 | |
| 224 | Ubiquitination | LLKKEEVKNVAELPT HHCHHHHCCHHHCCC | 49.32 | 29967540 | |
| 232 | Sumoylation | NVAELPTKVEEIPHP CHHHCCCCHHHCCCC | 45.79 | - | |
| 232 | Ubiquitination | NVAELPTKVEEIPHP CHHHCCCCHHHCCCC | 45.79 | 29967540 | |
| 232 | Sumoylation | NVAELPTKVEEIPHP CHHHCCCCHHHCCCC | 45.79 | - | |
| 248 | Phosphorylation | EEMNGINSIEMDSMR HHHCCCCCCCHHHHC | 20.29 | 20068231 | |
| 253 | Phosphorylation | INSIEMDSMRHSEDF CCCCCHHHHCCCHHH | 19.19 | 26074081 | |
| 257 | Phosphorylation | EMDSMRHSEDFKEKL CHHHHCCCHHHHHHC | 28.61 | 26074081 | |
| 273 | Phosphorylation | KGNGKRKSDTEFGNM CCCCCCCCCCCCHHH | 54.52 | 28985074 | |
| 275 | Phosphorylation | NGKRKSDTEFGNMKK CCCCCCCCCCHHHHH | 40.06 | 29449344 | |
| 283 | Ubiquitination | EFGNMKKKVKLSKEH CCHHHHHHHHHCHHH | 38.80 | - | |
| 285 | Ubiquitination | GNMKKKVKLSKEHQS HHHHHHHHHCHHHHH | 56.79 | - | |
| 292 | Phosphorylation | KLSKEHQSLEENQRQ HHCHHHHHHHHHHHH | 39.39 | 30576142 | |
| 307 | Phosphorylation | TRSKRKATSDTLESP HHHHHHHCCCCCCCC | 30.12 | 23684312 | |
| 308 | Phosphorylation | RSKRKATSDTLESPP HHHHHHCCCCCCCCC | 33.20 | 30576142 | |
| 310 | Phosphorylation | KRKATSDTLESPPKI HHHHCCCCCCCCCCC | 31.99 | 27794612 | |
| 313 | Phosphorylation | ATSDTLESPPKIIPK HCCCCCCCCCCCCCH | 50.00 | 29255136 | |
| 321 | Phosphorylation | PPKIIPKYISENESP CCCCCCHHCCCCCCC | 12.34 | 29396449 | |
| 323 | Phosphorylation | KIIPKYISENESPRP CCCCHHCCCCCCCCC | 31.14 | 25262027 | |
| 327 | Phosphorylation | KYISENESPRPSQKK HHCCCCCCCCCCCCC | 37.48 | 22167270 | |
| 331 | Phosphorylation | ENESPRPSQKKSRVK CCCCCCCCCCCCHHH | 56.78 | 22167270 | |
| 343 | Ubiquitination | RVKINWLKSATKQPS HHHHHHHHHHCCCCC | 29.65 | 29967540 | |
| 344 | Phosphorylation | VKINWLKSATKQPSI HHHHHHHHHCCCCCH | 38.71 | 26074081 | |
| 346 | Phosphorylation | INWLKSATKQPSILS HHHHHHHCCCCCHHH | 36.98 | 26074081 | |
| 347 | Acetylation | NWLKSATKQPSILSK HHHHHHCCCCCHHHH | 60.99 | 25953088 | |
| 350 | Phosphorylation | KSATKQPSILSKFCS HHHCCCCCHHHHHHH | 33.40 | 29978859 | |
| 353 | Phosphorylation | TKQPSILSKFCSLGK CCCCCHHHHHHHCCC | 23.24 | 26074081 | |
| 360 | Acetylation | SKFCSLGKITTNQGV HHHHHCCCCCCCCCC | 42.02 | 25953088 | |
| 360 | Ubiquitination | SKFCSLGKITTNQGV HHHHHCCCCCCCCCC | 42.02 | - | |
| 368 | Ubiquitination | ITTNQGVKGQSKENE CCCCCCCCCCCCCCC | 59.04 | 29967540 | |
| 387 | Phosphorylation | EDLGKCESDNTTNGC HHHCCCCCCCCCCCC | 45.70 | 26074081 | |
| 390 | Phosphorylation | GKCESDNTTNGCGLE CCCCCCCCCCCCCCC | 26.99 | 23663014 | |
| 391 | Phosphorylation | KCESDNTTNGCGLES CCCCCCCCCCCCCCC | 35.55 | 23663014 | |
| 398 | Phosphorylation | TNGCGLESPGNTVTP CCCCCCCCCCCEECC | 43.05 | 23663014 | |
| 402 | Phosphorylation | GLESPGNTVTPVNVN CCCCCCCEECCCCHH | 31.50 | 25850435 | |
| 404 | Phosphorylation | ESPGNTVTPVNVNEV CCCCCEECCCCHHHC | 21.34 | 26074081 | |
| 457 | Phosphorylation | REDFQDISVPVQEDE HHHHCCCCCCCCHHH | 28.76 | 29978859 | |
| 466 | Phosphorylation | PVQEDELSKVEESSE CCCHHHHHCHHCCCC | 32.38 | 28464451 | |
| 471 | Phosphorylation | ELSKVEESSEISPEP HHHCHHCCCCCCCCC | 21.55 | 30266825 | |
| 472 | Phosphorylation | LSKVEESSEISPEPK HHCHHCCCCCCCCCC | 42.08 | 30266825 | |
| 475 | Phosphorylation | VEESSEISPEPKTEM HHCCCCCCCCCCHHH | 21.11 | 29255136 | |
| 483 | Ubiquitination | PEPKTEMKTLRWAIS CCCCHHHHHHHHHHH | 37.87 | - | |
| 503 | Ubiquitination | ERIVGEDKYFCENCH HHHHCCCCEECCCCC | 35.60 | - | |
| 523 | Ubiquitination | ERSLLFDKMPEVITI HHHHHHCCCCCEEEE | 49.36 | - | |
| 529 | Phosphorylation | DKMPEVITIHLKCFA CCCCCEEEEEEHHHH | 13.91 | 20068231 | |
| 551 | Ubiquitination | CYGGGLSKINTPLLT EECCCHHCCCCCCCC | 45.05 | 21963094 | |
| 554 | Phosphorylation | GGLSKINTPLLTPLK CCHHCCCCCCCCCCE | 20.84 | 29978859 | |
| 558 | Phosphorylation | KINTPLLTPLKLSLE CCCCCCCCCCEECHH | 33.97 | 29978859 | |
| 610 | Ubiquitination | LNSLELDKGNFVVDQ CCCCCCCCCCEEEEC | 69.27 | 29967540 | |
| 623 | Ubiquitination | DQMCEIGKPEPLNEE ECCCCCCCCCCCCHH | 52.44 | 29967540 | |
| 656 | Ubiquitination | GGNTQPSKVLNKKNV CCCCCCCCCCCCCCH | 58.38 | 29967540 | |
| 675 | Ubiquitination | LLGGQKSKADYELYN ECCCCCCHHHHHHHH | 52.92 | 29967540 | |
| 678 | Phosphorylation | GQKSKADYELYNKAS CCCCHHHHHHHHHCC | 16.82 | - | |
| 681 | Phosphorylation | SKADYELYNKASNPD CHHHHHHHHHCCCHH | 11.59 | - | |
| 683 | Ubiquitination | ADYELYNKASNPDKV HHHHHHHHCCCHHHH | 39.37 | 29967540 | |
| 689 | Ubiquitination | NKASNPDKVASTAFA HHCCCHHHHHHHHHH | 40.74 | 21963094 | |
| 689 | Acetylation | NKASNPDKVASTAFA HHCCCHHHHHHHHHH | 40.74 | 26051181 | |
| 716 | Acetylation | THESDRNKESSDQTG CCHHHCCCCCCCCCC | 60.92 | 19814743 | |
| 716 | Ubiquitination | THESDRNKESSDQTG CCHHHCCCCCCCCCC | 60.92 | 29967540 | |
| 722 | Phosphorylation | NKESSDQTGINISGF CCCCCCCCCCCCHHH | 45.05 | 29978859 | |
| 727 | Phosphorylation | DQTGINISGFENKIS CCCCCCCHHHHHHHH | 32.70 | 25159151 | |
| 732 | Ubiquitination | NISGFENKISYVVQS CCHHHHHHHHHHHHH | 26.32 | 32015554 | |
| 741 | Ubiquitination | SYVVQSLKEYEGKWL HHHHHHHHHHCCEEE | 64.59 | 21906983 | |
| 746 | Ubiquitination | SLKEYEGKWLLFDDS HHHHHCCEEEEECCC | 23.80 | 22817900 | |
| 756 | Ubiquitination | LFDDSEVKVTEEKDF EECCCCCEEEECHHH | 39.11 | 22817900 | |
| 761 | Ubiquitination | EVKVTEEKDFLNSLS CCEEEECHHHHHHCC | 47.77 | 21906983 | |
| 766 | Phosphorylation | EEKDFLNSLSPSTSP ECHHHHHHCCCCCCC | 32.16 | 22199227 | |
| 768 | Phosphorylation | KDFLNSLSPSTSPTS HHHHHHCCCCCCCCC | 19.34 | 22199227 | |
| 770 | Phosphorylation | FLNSLSPSTSPTSTP HHHHCCCCCCCCCCC | 37.83 | 22199227 | |
| 771 | Phosphorylation | LNSLSPSTSPTSTPY HHHCCCCCCCCCCCE | 41.95 | 22199227 | |
| 772 | Phosphorylation | NSLSPSTSPTSTPYL HHCCCCCCCCCCCEE | 30.44 | 22199227 | |
| 774 | Phosphorylation | LSPSTSPTSTPYLLF CCCCCCCCCCCEEEE | 45.03 | 22199227 | |
| 775 | Phosphorylation | SPSTSPTSTPYLLFY CCCCCCCCCCEEEEE | 30.67 | 22199227 | |
| 776 | Phosphorylation | PSTSPTSTPYLLFYK CCCCCCCCCEEEEEE | 20.59 | 23090842 | |
| 778 | Phosphorylation | TSPTSTPYLLFYKKL CCCCCCCEEEEEECC | 19.00 | 23090842 | |
| 782 | Phosphorylation | STPYLLFYKKL---- CCCEEEEEECC---- | 13.74 | 23090842 | |
| 783 | Ubiquitination | TPYLLFYKKL----- CCEEEEEECC----- | 40.02 | 21890473 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of UBP1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UBP1_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67; SER-313 AND SER-475,AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67, AND MASSSPECTROMETRY. | |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-42, AND MASSSPECTROMETRY. | |
| "Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13, AND MASSSPECTROMETRY. | |